Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05272254 · ClinicalTrials.gov registry record · Phase 2
Povidone Iodine Efficacy Study
A Phase 2 study of Early Childhood Caries, sponsored by University of Rochester.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 202
- Enrollment target
- 1
- Study location
NCT05272254 is a Phase 2 study of Early Childhood Caries that is actively recruiting participants, run by University of Rochester. The registered enrollment target is 202 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05272254, a Phase 2 study of Early Childhood Caries, is actively recruiting participants, sponsored by University of Rochester.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 202 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single center, randomized, double-blind, placebo-controlled Phase II clinical trial (RCT) to evaluate the efficacy of topical 10% Polyvinylpyrrolidone-Iodine (PVPI) to prevent new caries lesions when applied to the teeth of children with Severe Early Childhood Caries (S-ECC). At baseline, following oral rehabilitation in the operating room {10% (PVPI + Fluoride Varnish (FV)} will be compared to the current standard of care (Placebo + FV). Study participants will be followed for approximately 24 months post-baseline. The study interventions post-baseline will be administered at 3, 6, 9, 12, 15, 18, and 21 months.
Conditions Studied
Interventions
- DRUG 10% povidone iodine + FV
- OTHER Placebo +FV
Study Locations (1)
New York
- University of Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 202 participants |
| Start Date | 2022-09-15 |
| Est. Completion | 2027-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05272254
The ClinicalTrials.gov registry entry for NCT05272254 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 202 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Early Childhood Caries appearing as the primary indexed condition, and to 2 interventions - of which 10% povidone iodine + FV is the first listed.
NCT05272254 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05272254 about?
NCT05272254 is a clinical study titled "Povidone Iodine Efficacy Study". This is a single center, randomized, double-blind, placebo-controlled Phase II clinical trial (RCT) to evaluate the efficacy of topical 10% Polyvinylpyrrolidone-Iodine (PVPI) to prevent new caries lesions when applied to the teeth of children with Severe Early Childhood Caries (S-ECC). At baseline, ...
What is the current status of trial NCT05272254?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 202 participants. The study started on 2022-09-15. Estimated completion is 2027-05.
What conditions does trial NCT05272254 study?
This clinical trial studies the following conditions: Early Childhood Caries.
What interventions are being tested in trial NCT05272254?
The interventions under investigation include: 10% povidone iodine + FV (DRUG), Placebo +FV (OTHER).
Who is sponsoring clinical trial NCT05272254?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05272254 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Early Childhood Caries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.